CVS Health will close hundreds of drugstores over the next three years, as the retail giant adjusts to changing customer needs and converts to new store formats.
The company said Thursday that it will close about 300 stores a year for the next three years as it looks to reduce store count density in some locations.
The total of around 900 amounts to nearly a tenth of the roughly 10,000 retail locations CVS Health operates. The company also sells insurance and runs prescription drug plans for big clients like insurers and employers.
The company expects to take an impairment charge of between $1 billion and $1.2 billion in the fourth quarter for the closures. That charge won’t affect the company’s earnings forecast.
Drugstore chains like CVS and Walgreens built thousands of locations around the country to get closer to consumer homes. But in recent years, the explosive growth of online shopping has blunted the demand for such in-person convenience.
Shares of Woonsocket, Rhode Island-based CVS Health Corp. rose slightly Thursday morning while broader trading indexes dipped.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
